Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04403139
PHASE4

VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination

Sponsor: University of Washington

View on ClinicalTrials.gov

Summary

To evaluate the effect of intramuscular RZV vaccine on VZV-specific skin TRM and circulating T-cells

Key Details

Gender

All

Age Range

30 Years - Any

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2022-04-27

Completion Date

2026-02

Last Updated

2025-04-03

Healthy Volunteers

Yes

Interventions

DRUG

Shingrix

All participants will receive the FDA-approved recombinant zoster (RZV) vaccine (Shingrix) given at the approved dose and schedule.

Locations (1)

University of Washington Virology Research Clinic

Seattle, Washington, United States